Clinical trial
Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of…
NCT00083044 · Northwestern University, Other · Withdrawn
Key facts
| NCT number | NCT00083044 |
|---|---|
| Title | Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy |
| Official title | Surrogate Endpoints in Prevention Studies and Ductal Lavage |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Study type | Observational |
| Conditions | Breast Cancer |
| Enrollment | 0 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | May 17, 2004 |
| Last update posted | Apr 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: